Top Midday Stories: Merck to Acquire Cidara Therapeutics for $9.2 Billion; Walmart Names John Furner as CEO

MT Newswires Live
11/15

The S&P 500 and Nasdaq Composite rose in midday trading, erasing earlier declines, and the Dow Jones Industrial Average eased.

In company news, Merck (MRK) agreed to acquire Cidara Therapeutics (CDTX) for $9.2 billion, or $221.50 a share in cash. The transaction is expected to close in Q1 2026. Merck shares rose 1.5% at midday, and Cidara more than doubled.

Walmart (WMT) said its board elected John Furner as president and chief executive officer, effective Feb. 1, 2026. Furner will succeed Doug McMillon, who will retire on Jan. 31 and remain on the board until the next annual shareholders meeting. Furner has served as president and CEO of Walmart US since 2019. Walmart shares fell 1.4%.

Applied Materials (AMAT) reported fiscal Q4 adjusted earnings late Thursday of $2.17 per diluted share, down from $2.32 a year earlier. Analysts polled by FactSet expected $2.11. Revenue in the three months ended Oct. 26 fell to $6.8 billion from $7.05 billion. Analysts projected $6.68 billion. The company expects Q1 adjusted EPS of $2.18 on revenue of $6.85 billion. Analysts forecast EPS of $2.14 on revenue of $6.79 billion. Applied Materials shares edged up 0.1% at midday.

StubHub Holdings (STUB) reported a Q3 loss late Thursday of $4.27 per diluted share, widening from the loss of $0.15 a year earlier. Analysts polled by FactSet expected a loss of $2.87. Revenue rose to $468.1 million from $433.8 million. Analysts projected $451.8 million. StubHub shares tumbled 20% at midday after the company withheld guidance.

Price: 94.29, Change: +1.35, Percent Change: +1.46

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10